CAR-T Developers Will Need Randomized Trials as FDA Eyes Tighter Approval Requirements
For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including already-approved CAR T products.
CAR-T Developers Will Need Randomized Trials as FDA Eyes Tighter Approval Requirements Read More »
